FIGURE
Figure 4
- ID
- ZDB-FIG-210716-90
- Publication
- Lima Cunha et al., 2021 - REP1-deficiency causes systemic dysfunction of lipid metabolism and oxidative stress in choroideremia
- Other Figures
- All Figure Page
- Back to All Figure Page
Figure 4
Disturbance of sphingolipid metabolism in CHM patients. (A) General sphingolipid metabolism pathway with compounds differentially detected in CHM patients highlighted in red (increased) or green (decreased) compared with control levels. (B–I) Scatter dot plots of key metabolite levels in both control (blue) and choroideremia (red) plasma samples. Lines indicate mean ± SD (n = 25). P value was determined using matched pair t tests. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. SM, sphingomyelin. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ JCI Insight